Paul Tudor Jones Moderna, Inc. Transaction History

Tudor Investment Corp Et Al

$26.8 Billion
Q3 2024

A detailed history of Paul Tudor Jones (Tudor Investment Corp Et Al) transactions in Moderna, Inc. stock. As of the latest transaction made, Tudor Investment Corp Et Al holds 153,098 shares of MRNA stock, worth $6.17 Million. This represents 0.04% of its overall portfolio holdings.

Number of Shares

153,098

Previous 124,335 23.13%

Holding current value

$6.17 Million

Previous $14.8 Million 30.7%

% of portfolio

0.04%

Previous 0.08%

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	BUY	$63.64 - $125.14 $1.83 Million - $3.6 Million	28,763 Added 23.13%	153,098 $10.2 Million
Q2 2024 Aug 14, 2024	BUY	$101.21 - $166.61 $12.6 Million - $20.7 Million	124,335 New	124,335 $14.8 Million
Q4 2022 Feb 14, 2023	SELL	$118.38 - $210.04 $3.15 Million - $5.58 Million	-26,582 Reduced 73.11%	9,779 $1.76 Million
Q3 2022 Nov 14, 2022	BUY	$118.07 - $194.18 $2.6 Million - $4.28 Million	22,026 Added 153.65%	36,361 $4.3 Million
Q2 2022 Aug 15, 2022	BUY	$117.13 - $176.59 $995,839 - $1.5 Million	8,502 Added 145.76%	14,335 $2.05 Million
Q1 2022 May 16, 2022	SELL	$126.46 - $235.05 $486,744 - $904,707	-3,849 Reduced 39.75%	5,833 $1.01 Million
Q4 2021 Feb 14, 2022	SELL	$225.82 - $368.51 $3.21 Million - $5.24 Million	-14,215 Reduced 59.48%	9,682 $2.46 Million
Q3 2021 Nov 15, 2021	BUY	$221.9 - $484.47 $3.24 Million - $7.08 Million	14,618 Added 157.54%	23,897 $9.2 Million
Q2 2021 Aug 16, 2021	SELL	$129.91 - $234.98 $2.53 Million - $4.58 Million	-19,487 Reduced 67.74%	9,279 $2.18 Million
Q1 2021 May 17, 2021	BUY	$109.18 - $185.98 $2.05 Million - $3.5 Million	18,821 Added 189.25%	28,766 $3.77 Million
Q4 2020 Feb 16, 2021	BUY	$65.74 - $169.86 $112,218 - $289,951	1,707 Added 20.72%	9,945 $1.04 Million
Q3 2020 Nov 16, 2020	BUY	$54.34 - $94.85 $447,652 - $781,374	8,238 New	8,238 $583,000

Others Institutions Holding MRNA

# of Institutions

953

Shares Held

240M

Call Options Held

10.6M

Put Options Held

18.7M

View Full List

About Moderna, Inc.

Ticker MRNA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 391,200,000
Market Cap $15.8B
Description
Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, resp...

More about MRNA

Track Paul Tudor Jones's Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Tudor Investment Corp Et Al, based on Form 13F filings with the SEC.

News

Stay updated on Tudor Investment Corp Et Al and Paul Tudor Jones with notifications on news.

Account